Cargando…

3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs

SIMPLE SUMMARY: Three-dimensional (3D) cell culture models have been proposed as alternatives for initial drug screening to increase drug development efficiency. In addition to their ability to reproduce key aspects of the tumor architecture and microenvironment, 3D cell culture models may help decr...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Mélanie A. G., Xavier, Cristina P. R., Pereira, Rúben F., Petrikaitė, Vilma, Vasconcelos, M. Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749977/
https://www.ncbi.nlm.nih.gov/pubmed/35008353
http://dx.doi.org/10.3390/cancers14010190
_version_ 1784631356108570624
author Barbosa, Mélanie A. G.
Xavier, Cristina P. R.
Pereira, Rúben F.
Petrikaitė, Vilma
Vasconcelos, M. Helena
author_facet Barbosa, Mélanie A. G.
Xavier, Cristina P. R.
Pereira, Rúben F.
Petrikaitė, Vilma
Vasconcelos, M. Helena
author_sort Barbosa, Mélanie A. G.
collection PubMed
description SIMPLE SUMMARY: Three-dimensional (3D) cell culture models have been proposed as alternatives for initial drug screening to increase drug development efficiency. In addition to their ability to reproduce key aspects of the tumor architecture and microenvironment, 3D cell culture models may help decrease the use of laboratory animals in drug testing, in accordance with the 3R principles (Replacement, Reduction, Refinement). This review aims to help researchers making a transition from two-dimensional (2D) to 3D cell culture models for drug screening, by discussing the impact of 3D models on cancer research, their advantages, limitations, and compatibility with high-throughput screenings. It also outlines the relevance of available readouts provided by such models as well as the importance of incorporating key microenvironmental cues towards improving the predictive value of drug efficacy and safety. ABSTRACT: Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomimetic alternatives for initial drug screening, allowing the improvement of the efficiency of drug development. These models are gaining popularity, given their ability to reproduce key aspects of the tumor microenvironment, concerning the 3D tumor architecture as well as the interactions of tumor cells with the extracellular matrix and surrounding non-tumor cells. The development of accurate 3D models may become beneficial to decrease the use of laboratory animals in scientific research, in accordance with the European Union’s regulation on the 3R rule (Replacement, Reduction, Refinement). This review focuses on the impact of 3D cell culture models on cancer research, discussing their advantages, limitations, and compatibility with high-throughput screenings and automated systems. An insight is also given on the adequacy of the available readouts for the interpretation of the data obtained from the 3D cell culture models. Importantly, we also emphasize the need for the incorporation of additional and complementary microenvironment elements on the design of 3D cell culture models, towards improved predictive value of drug efficacy.
format Online
Article
Text
id pubmed-8749977
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87499772022-01-12 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs Barbosa, Mélanie A. G. Xavier, Cristina P. R. Pereira, Rúben F. Petrikaitė, Vilma Vasconcelos, M. Helena Cancers (Basel) Review SIMPLE SUMMARY: Three-dimensional (3D) cell culture models have been proposed as alternatives for initial drug screening to increase drug development efficiency. In addition to their ability to reproduce key aspects of the tumor architecture and microenvironment, 3D cell culture models may help decrease the use of laboratory animals in drug testing, in accordance with the 3R principles (Replacement, Reduction, Refinement). This review aims to help researchers making a transition from two-dimensional (2D) to 3D cell culture models for drug screening, by discussing the impact of 3D models on cancer research, their advantages, limitations, and compatibility with high-throughput screenings. It also outlines the relevance of available readouts provided by such models as well as the importance of incorporating key microenvironmental cues towards improving the predictive value of drug efficacy and safety. ABSTRACT: Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomimetic alternatives for initial drug screening, allowing the improvement of the efficiency of drug development. These models are gaining popularity, given their ability to reproduce key aspects of the tumor microenvironment, concerning the 3D tumor architecture as well as the interactions of tumor cells with the extracellular matrix and surrounding non-tumor cells. The development of accurate 3D models may become beneficial to decrease the use of laboratory animals in scientific research, in accordance with the European Union’s regulation on the 3R rule (Replacement, Reduction, Refinement). This review focuses on the impact of 3D cell culture models on cancer research, discussing their advantages, limitations, and compatibility with high-throughput screenings and automated systems. An insight is also given on the adequacy of the available readouts for the interpretation of the data obtained from the 3D cell culture models. Importantly, we also emphasize the need for the incorporation of additional and complementary microenvironment elements on the design of 3D cell culture models, towards improved predictive value of drug efficacy. MDPI 2021-12-31 /pmc/articles/PMC8749977/ /pubmed/35008353 http://dx.doi.org/10.3390/cancers14010190 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Barbosa, Mélanie A. G.
Xavier, Cristina P. R.
Pereira, Rúben F.
Petrikaitė, Vilma
Vasconcelos, M. Helena
3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title_full 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title_fullStr 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title_full_unstemmed 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title_short 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
title_sort 3d cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749977/
https://www.ncbi.nlm.nih.gov/pubmed/35008353
http://dx.doi.org/10.3390/cancers14010190
work_keys_str_mv AT barbosamelanieag 3dcellculturemodelsasrecapitulatorsofthetumormicroenvironmentforthescreeningofanticancerdrugs
AT xaviercristinapr 3dcellculturemodelsasrecapitulatorsofthetumormicroenvironmentforthescreeningofanticancerdrugs
AT pereirarubenf 3dcellculturemodelsasrecapitulatorsofthetumormicroenvironmentforthescreeningofanticancerdrugs
AT petrikaitevilma 3dcellculturemodelsasrecapitulatorsofthetumormicroenvironmentforthescreeningofanticancerdrugs
AT vasconcelosmhelena 3dcellculturemodelsasrecapitulatorsofthetumormicroenvironmentforthescreeningofanticancerdrugs